Table 1 Basic and clinical characteristics of the patients
DCM LGE group (n = 10) | DCM Non-LGE group (n = 20) | Control group (n = 15) | P value | |
|---|---|---|---|---|
Age (mean ± SD) | 39 ± 8.12 | 38.4 ± 10.86 | 33.72 ± 2.72 | 0.473¥ |
Sex (n; %) | ||||
Male | 7 (70%) | 17 (85%) | 14 (93.3%) | 0.422▀ |
Female | 3 (30%) | 3 (15%) | 1 (6.7%) | |
Body surface area (BSA) (mean ± SD) | 1.92 ± 0.14 | 1.88 ± 0.17 | 1.92 ± 0.1 | 0.609¥ |
Smokers (n; %) | Zero (0%) | 5 (25%) | 1 (6.7%) | 0.156▀ |
Vital data (mean ± SD) | ||||
Pulse | 72.1 ± 4.48 | 69.45 ± 6.56 | 68.87 ± 5.37 | 0.368¥ |
Systolic blood pressure | 110.5 ± 4.97 | 113.75 ± 7.05 | 114.67 ± 4.81 | 0.223¥ |
Diastolic blood pressure | 71 ± 5.16 | 73.5 ± 6.3 | 74.67 ± 4.42 | 0.27¥ |
Co-morbidities (n; %) | ||||
Diabetes Milletus (DM) | 2 (20%) | 2 (10%) | 0.584* | |
Atrial fibrillation (AF) | 4 (40%) | 4 (20%) | 0.384* | |
Drugs (n; %) | ||||
Beta blockers | 8 (80%) | 15 (75%) | 0.99* | |
ACEI/ARBS | 10 (100%) | 17 (85%) | 0.532* | |
Diuretic | 5 (50%) | 6 (30%) | 0.284* | |
New York Heart Association (NYHA) (n; %) | ||||
Class 2 | 4 (40%) | 16 (80%) | 0.045* | |
Class 3 | 6 (60%) | 4 (20%) | ||
Functional parameters of the left ventricle (LV) (mean ± SD) | ||||
LVEF (%) | 22.5 ± 5.28 | 29.05 ± 3.94 | 62.07 ± 1.67 | < 0.001¥ |
LVESV (ml) | 228.09 ± 57.03 | 167.47 ± 33.1 | 63.94 ± 5.75 | |
LVESV index (ml/m2) | 118.84 ± 28.51 | 89.55 ± 18.41 | 33.22 ± 2.63 | |
LVEDV (ml) | 294.91 ± 62.1 | 235.78 ± 38.32 | 170.65 ± 10.87 | |
LVEDV index (ml/m2) | 153.54 ± 29.55 | 125.96 ± 20.74 | 88.78 ± 5.28 | |
ED LV mass (gm) | 169.51 ± 27.38 | 147.91 ± 22.53 | 86.91 ± 9.07 | |
ED LV mass index (gm/m2) | 88.24 ± 11.15 | 78.67 ± 9.25 | 45.12 ± 3.69 | |